RhumbLine Advisers
DMTK

RhumbLine Advisers’s DermTech, Inc. Common Stock DMTK Stock Holding History

RhumbLine Advisers’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-25,571
Closed -$375K – 3272
2022
Q1 		$375K Buy
25,571
+3,036
+13% +$40.6K ﹤0.01% 2553
2021
Q4 		$356K Sell
22,535
-292
-1% -$7.01K ﹤0.01% 2648
2021
Q3 		$733K Sell
22,827
-5
-0% -$176 ﹤0.01% 2370
2021
Q2 		$949K Buy
22,832
+14,923
+189% +$613K ﹤0.01% 2266
2021
Q1 		$402K Buy
+7,909
New +$414K ﹤0.01% 2586

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

RhumbLine Advisers's DMTK Position: Q2 2022 in Review

RhumbLine Advisers sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2022, closing a stake of 25,571 shares — an estimated $375K sold.

RhumbLine Advisers first reported a position in DMTK in Q1 2021 and held it in 5 quarters. The position peaked at $949K in Q2 2021. 134 funds tracked by Wall St. Rank hold DMTK as of Q2 2022.

  • RhumbLine Advisers reported no remaining DermTech, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • RhumbLine Advisers sold 25,571 DermTech, Inc. Common Stock shares in Q2 2022, an estimated $375K.
  • RhumbLine Advisers first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • RhumbLine Advisers's DermTech, Inc. Common Stock position peaked at $949K in Q2 2021.
  • 134 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2022.

Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.